NEUROSENSE proposes a novel and visionary technology resulting from the demonstration of the upstream role of arousal in the sudden unexpected death in epilepsy (SUDEP). SUDEP is a societal challenge for which there is neither prediction nor prevention.
Partners
The NEUROSENSE consortium is composed of 7 organizations from 5 different countries, 3 R&D Centers, 2 Hospitals and 2 SMEs.
